Inflammasomes in carcinogenesis and anticancer immune responses Review uri icon


MeSH Major

  • Inflammasomes
  • Neoplasms


  • In the complex interplay between malignant cells and their microenvironment, caspase-1 activation complexes (inflammasomes) have contrasting roles. Inflammasomes may operate at the cell-autonomous level to eliminate malignant precursors through programmed cell death or, conversely, may stimulate the production of trophic factors for cancer cells and their stroma. In inflammatory cells, caspase-1 activation can fuel a cycle that leads to sterile inflammation and carcinogenesis, whereas in antigen-presenting cells, inflammasomes can stimulate anticancer immune responses. The inhibition of inflammasomes or neutralization of their products, mainly interleukin 1β (IL-1β) and IL-18, has profound effects on carcinogenesis and tumor progression. Thus, inflammasomes are promising therapeutic targets in cancer-related clinical conditions. Here we discuss present and future indications for the clinical use of inflammasome inhibitors.

publication date

  • April 2012



  • Review



  • eng

Digital Object Identifier (DOI)

  • 10.1038/ni.2224

PubMed ID

  • 22430787

Additional Document Info

start page

  • 343

end page

  • 51


  • 13


  • 4